【Session 2a】The Cancer Terminator: Our Immune System
Future Science Prize Symposium 2018.11.17
Speeches
Lecturer Profiles
10:30 - 12:30 Session 2a: The Cancer Terminator: Our Immune System
10:30 - 10:35 Opening Remark
- − James Ding, General Partner and Managing Director, GSR Venture, LLP; Member, Council of the Future Forum
10:35 - 11:05 Keynote Speech
Conceptual and practical advances in cancer immunotherapy
- − Lieping Chen, UTC Professor in Cancer Research; Professor of Immunobiology, Medicine and Dermatology; Director, Cancer Immunology Program, Yale University School of Medicine; Member, Academia Sinica
11:05 - 11:35 Keynote Speech
Six steps of immune response
- − Yongjun Liu, Global Head of Research, Sanofi; Member, Science Committee of the Future Science Prize
11:35 - 12:30 Panel
Moderator
- − Charlene Liao, PhD, President and CEO of Immune-Onc Therapeutics, Inc.
Panelists
- − Lieping Chen (see above)
- − Jiuwei Cui, Director, Cancer Center, the First Hospital of Jilin University
- − Yang-Xin Fu, Professor of Pathology, University of Texas, Southwestern Medical Center; Mary Nell and Ralph B. Rogers Professorship in Immunology
- − Yongjun Liu (see above)
- − Yuting Ma, Researcher, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences; PhD supervisor in Peking Union Medical College
10:30 - 12:30 Session 2a: The Cancer Terminator: Our Immune System
10:30 - 10:35 Opening Remark
- − James Ding, General Partner and Managing Director, GSR Venture, LLP; Member, Council of the Future Forum
10:35 - 11:05 Keynote Speech
Conceptual and practical advances in cancer immunotherapy
- − Lieping Chen, UTC Professor in Cancer Research; Professor of Immunobiology, Medicine and Dermatology; Director, Cancer Immunology Program, Yale University School of Medicine; Member, Academia Sinica
11:05 - 11:35 Keynote Speech
Six steps of immune response
- − Yongjun Liu, Global Head of Research, Sanofi; Member, Science Committee of the Future Science Prize
11:35 - 12:30 Panel
Moderator
- − Charlene Liao, PhD, President and CEO of Immune-Onc Therapeutics, Inc.
Panelists
- − Lieping Chen (see above)
- − Jiuwei Cui, Director, Cancer Center, the First Hospital of Jilin University
- − Yang-Xin Fu, Professor of Pathology, University of Texas, Southwestern Medical Center; Mary Nell and Ralph B. Rogers Professorship in Immunology
- − Yongjun Liu (see above)
- − Yuting Ma, Researcher, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences; PhD supervisor in Peking Union Medical College
Related Reading
